APVO
$44.39
Aptevo Therapeutics
$.58
1.32%
Earnings Details
3rd Quarter September 2020
Tweet Share Watch
Summary

Aptevo Therapeutics (APVO) Recent Earnings

Aptevo Therapeutics (APVO) reported a 3rd Quarter September 2020 loss of $2.15 per share on revenue of $1.5 million. The consensus estimate was a loss of $2.05 per share on revenue of $0.5 million. Revenue fell 83.8% compared to the same quarter a year ago.

Results
Reported Earnings
($2.15)
Earnings Whisper
-
Consensus Estimate
($2.05)
Reported Revenue
$1.5 Mil
Revenue Estimate
$0.5 Mil
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release